QIAGEN, Clovis Oncology Collaborate for Companion Diagnostic Targeting Drug-Resistant EGFR Mutations - Clinical Lab Products

首页> 外文期刊>Clinical Lab Products >QIAGEN, Clovis Oncology Collaborate for Companion Diagnostic Targeting Drug-Resistant EGFR Mutations - Clinical Lab Products

【24h】

QIAGEN, Clovis Oncology Collaborate for Companion Diagnostic Targeting Drug-Resistant EGFR Mutations - Clinical Lab Products

机译：QIAGEN与Clovis肿瘤学合作针对靶向耐药性EGFR突变的同伴诊断-临床实验室产品

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Lab Products》 |2013年第2013期|共页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类实验医学、医学实验;
关键词

相似文献

外文文献
中文文献
专利

1. QIAGEN, Clovis Oncology Collaborate for Companion Diagnostic Targeting Drug-Resistant EGFR Mutations - Clinical Lab Products [J] . Clinical Lab Products . 2013,第2013期

机译：QIAGEN与Clovis肿瘤学合作针对靶向耐药性EGFR突变的同伴诊断-临床实验室产品
2. QIAGEN, Clovis Oncology Collaborate for Companion Diagnostic Targeting Drug-Resistant EGFR Mutations - Clinical Lab Products [J] . Clinical Lab Products . 2013,第2013期

机译：QIAGEN与Clovis肿瘤学合作针对靶向耐药性EGFR突变的同伴诊断-临床实验室产品
3. Clovis Oncology, Ventana to Develop Companion Diagnostic Test for CO-101 - Clinical Lab Products [J] . Clinical Lab Products . 2010,第2010期

机译：Ventana的Clovis肿瘤学公司将开发针对CO-101的伴随诊断测试-临床实验室产品
4. System Dynamics in New Product Forecasting: Collaborative Use of Patient Based Forecast Model for an Oncology Drug [C] . Eckhard Scheufler, Peter Lacey International Conference of the System Dynamics Society . 2016

机译：新产品预测中的系统动态：基于患者的肿瘤药物预测模型的协作利用
5. Epidermal growth factor receptor (EGFR) mutations and tumor-specific targeting of malignant glioma by vaccine-based immunotherapeutic approaches. [D] . Ciesielski, Michael John. 2003

机译：表皮生长因子受体（EGFR）突变和恶性神经胶质瘤的肿瘤特异性靶向通过基于疫苗的免疫治疗方法。
6. Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea [O] . Eun-A Lim, Haeyoung Lee, Eunmi Bae, 2011

机译：韩国晚期非小细胞肺癌患者EGFR突变和一线靶向治疗的同伴诊断测试的经济评估
7. Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea. [O] . Eun-A Lim, Haeyoung Lee, Eunmi Bae, 2016

机译：韩国晚期非小细胞肺癌患者EGFR突变和一线靶向治疗伴随诊断检测的经济学评价。

QIAGEN, Clovis Oncology Collaborate for Companion Diagnostic Targeting Drug-Resistant EGFR Mutations - Clinical Lab Products

著录项

相似文献

相关主题

期刊订阅